InsiderTrades.com logo

CMND Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $323,857.80
Insider Selling (Last 12 Months): $27,022.92

Clearmind Medicine Insider Trading History Chart

This chart shows the insider buying and selling history at Clearmind Medicine by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Clearmind Medicine Share Price & Price History

Current Price: $3.34
Price Change: +0.30 (1.20%)
As of 06/12/2026 04:00 PM ET

This chart shows the closing price history over time for CMND up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Clearmind Medicine Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/11/2026Financial Lp HrtMajor ShareholderSell225,191$0.12$27,022.921,838,075View SEC Filing Icon  
6/10/2026Financial Lp HrtMajor ShareholderBuy2,159,052$0.15$323,857.802,063,266View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Clearmind Medicine (NASDAQ:CMND)

96.05% of Clearmind Medicine stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CMND by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Clearmind Medicine Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/5/2025AdvisorShares Investments LLC224,378$0.23M0.0%+9.0%4.105%Search for SEC Filing on Google Icon
8/4/2025AdvisorShares Investments LLC205,933$0.18M0.0%-6.8%4.823%Search for SEC Filing on Google Icon
2/17/2025Citadel Advisors LLC38,158$53K0.0%+115.2%0.894%Search for SEC Filing on Google Icon
2/11/2025Virtu Financial LLC39,479$54K0.0%N/A0.925%Search for SEC Filing on Google Icon
8/8/2024AdvisorShares Investments LLC128,641$0.21M0.0%+14.2%7.598%Search for SEC Filing on Google Icon
7/24/2024Cornerstone Wealth Group LLC20,000$34K0.0%N/A1.183%Search for SEC Filing on Google Icon
2/14/2024AdvisorShares Investments LLC92,693$0.26M0.1%-24.8%5.485%Search for SEC Filing on Google Icon
11/13/2023Warberg Asset Management LLC220,000$35K0.0%N/A3.143%Search for SEC Filing on Google Icon
8/9/2023AdvisorShares Investments LLC123,257$58K0.0%-19.6%1.761%Search for SEC Filing on Google Icon
5/9/2023AdvisorShares Investments LLC153,257$0.18M0.1%N/A2.189%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Clearmind Medicine logo
Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors. The company also develops MEAI compound which is in IND-enabling study for the treatment of alcohol use disorder; and is in pre-clinical study for treatment of obesity, weight loss, metabolic disorder, and addiction. In addition, it has a collaboration with SciSparc Ltd. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome; and with Yissum Research Development Company of the Hebrew University of Jerusalem for the discovery and development of novel psychedelic-derived therapeutics to treat mental disorders. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
Read More on Clearmind Medicine

Today's Range

Now: $3.34
Low: $3.26
High: $3.55

50 Day Range

MA: $6.37
Low: $2.26
High: $14.30

52 Week Range

Now: $3.34
Low: $2.10
High: $524.00

Volume

161,123 shs

Average Volume

1,154,215 shs

Market Capitalization

$3.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.64

Who are the company insiders with the largest holdings of Clearmind Medicine?

Clearmind Medicine's top insider shareholders include:
  1. Financial Lp Hrt (Major Shareholder)
Learn More about top insider investors at Clearmind Medicine.